Ocular Oncology Yesterday And Today

    January 2024 in “ Wiadomości Lekarskie
    Bożena Romanowska-Dixon
    Image
    Studysummary This study reports that while primary treatment for uveal melanoma has a very high success rate, treating distant metastases, particularly in the liver, remains challenging. Tebentafusp, dependent on HLA-A expression, is the first drug to extend patient survival.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →